| Pretreatment with anti-thymocyte globulin versus no anti-thymocyte globulin in patients with haematological malignancies undergoing haemopoietic cell transplantation from … I Walker, T Panzarella, S Couban, F Couture, G Devins, M Elemary, ... The Lancet Oncology 17 (2), 164-173, 2016 | 327 | 2016 |
| Five new pedigrees with inherited RUNX1 mutations causing familial platelet disorder with propensity to myeloid malignancy CJ Owen, CL Toze, A Koochin, DL Forrest, CA Smith, JM Stevens, ... Blood, The Journal of the American Society of Hematology 112 (12), 4639-4645, 2008 | 276 | 2008 |
| Cytogenetic abnormalities in primary myelodysplastic syndrome are highly predictive of outcome after allogeneic bone marrow transplantation TJ Nevill, HC Fung, JD Shepherd, DE Horsman, SH Nantel, ... Blood, The Journal of the American Society of Hematology 92 (6), 1910-1917, 1998 | 210 | 1998 |
| Admission of bone marrow transplant recipients to the intensive care unit: outcome, survival and prognostic factors SR Jackson, MG Tweeddale, MJ Barnett, JJ Spinelli, HJ Sutherland, ... Bone marrow transplantation 21 (7), 697-704, 1998 | 182 | 1998 |
| High-dose chemotherapy and autologous stem cell transplantation for primary refractory or relapsed Hodgkin lymphoma: long-term outcome in the first 100 patients treated in … JC Lavoie, JM Connors, GL Phillips, DE Reece, MJ Barnett, DL Forrest, ... Blood 106 (4), 1473-1478, 2005 | 174 | 2005 |
| Lymphoproliferative disorders following allogeneic bone marrow transplantation: the Vancouver experience INM Micallef, M Chhanabhai, RD Gascoyne, JD Shepherd, HC Fung, ... Bone marrow transplantation 22 (10), 981-987, 1998 | 133 | 1998 |
| Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group D Villa, M Crump, T Panzarella, KJ Savage, CL Toze, DA Stewart, ... J Clin Oncol 31 (9), 1164-1171, 2013 | 126 | 2013 |
| Leukocyte count as a predictor of death during remission induction in acute myeloid leukemia MJ Greenwood, MD Seftel, C Richardson, D Barbaric, MJ Barnett, ... Leukemia & lymphoma 47 (7), 1245-1252, 2006 | 118 | 2006 |
| Myeloablative allografting for chronic lymphocytic leukemia: evidence for a potent graft-versus-leukemia effect associated with graft-versus-host disease CL Toze, A Galal, MJ Barnett, JD Shepherd, EA Conneally, DE Hogge, ... Bone marrow transplantation 36 (9), 825-830, 2005 | 104 | 2005 |
| Cytogenetic and molecular responses to standard-dose imatinib in chronic myeloid leukemia are correlated with Sokal risk scores and duration of therapy but not trough imatinib … DL Forrest, S Trainor, RR Brinkman, MJ Barnett, DE Hogge, TJ Nevill, ... Leukemia research 33 (2), 271-275, 2009 | 103 | 2009 |
| Allogeneic haematopoietic stem‐cell transplantation for relapsed and refractory aggressive histology non‐Hodgkin lymphoma RT Doocey, CL Toze, JM Connors, TJ Nevill, RD Gascoyne, MJ Barnett, ... British journal of haematology 131 (2), 223-230, 2005 | 103 | 2005 |
| Long-term outcome after allo-SCT: close follow-up on a large cohort treated with myeloablative regimens YR Abou-Mourad, BC Lau, MJ Barnett, DL Forrest, DE Hogge, SH Nantel, ... Bone marrow transplantation 45 (2), 295-302, 2010 | 98 | 2010 |
| Stem cell transplantation for myelofibrosis: a report from two Canadian centers A Daly, K Song, T Nevill, S Nantel, C Toze, D Hogge, D Forrest, J Lavoie, ... Bone marrow transplantation 32 (1), 35-40, 2003 | 97 | 2003 |
| The complex genetic landscape of familial MDS and AML reveals pathogenic germline variants A Rio-Machin, T Vulliamy, N Hug, A Walne, K Tawana, S Cardoso, ... Nature communications 11 (1), 1044, 2020 | 93 | 2020 |
| Early-onset autoimmune hepatitis is associated with a C4A gene deletion LJ Scully, C Toze, DPS Sengar, R Goldstein Gastroenterology 104 (5), 1478-1484, 1993 | 93 | 1993 |
| Primary therapy for adults with T-cell lymphoblastic lymphoma with hematopoietic stem-cell transplantation results in favorable outcomes KW Song, MJ Barnett, RD Gascoyne, M Chhanabhai, DL Forrest, ... Annals of oncology 18 (3), 535-540, 2007 | 89 | 2007 |
| Heterogeneity of chronic graft-versus-host disease biomarkers: association with CXCL10 and CXCR3+ NK cells A Kariminia, SG Holtan, S Ivison, J Rozmus, MJ Hebert, PJ Martin, SJ Lee, ... Blood, The Journal of the American Society of Hematology 127 (24), 3082-3091, 2016 | 88 | 2016 |
| Allogeneic bone marrow transplantation for low-grade lymphoma and chronic lymphocytic leukemia CL Toze, JD Shepherd, JM Connors, NJ Voss, RD Gascoyne, DE Hogge, ... Bone marrow transplantation 25 (6), 605-612, 2000 | 86 | 2000 |
| High-dose therapy and autologous hematopoietic stem-cell transplantation does not increase the risk of second neoplasms for patients with Hodgkin's lymphoma: a comparison of … DL Forrest, DE Hogge, TJ Nevill, SH Nantel, MJ Barnett, JD Shepherd, ... Journal of clinical oncology 23 (31), 7994-8002, 2005 | 72 | 2005 |
| Long‐term disease‐free survival of patients with advanced follicular lymphoma after allogeneic bone marrow transplantation CL Toze, MJ Barnett, JM Connors, RD Gascoyne, NJ Voss, SH Nantel, ... British journal of haematology 127 (3), 311-321, 2004 | 72 | 2004 |
